Stay updated on BMS-813160 Combo in PDAC Clinical Trial
Sign up to get notified when there's something new on the BMS-813160 Combo in PDAC Clinical Trial page.

Latest updates to the BMS-813160 Combo in PDAC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new study involving Nab-paclitaxel for treating pancreatic ductal adenocarcinoma, with significant changes in the study's design and collaborators. The previous study details have been largely removed, indicating a shift in focus or methodology.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 24, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe web page has updated its version from v2.14.2 to v2.14.3 and changed the date from 2025-01-24 to 2025-03-25.SummaryDifference0.2%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to BMS-813160 Combo in PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-813160 Combo in PDAC Clinical Trial page.